Institute for Protein Innovation
@ipiproteins
Followers
2K
Following
969
Media
341
Statuses
1K
We advance protein science to accelerate research and improve human health. Find us on Bluesky, LinkedIn and Instagram 🧑🔬
Boston, MA
Joined May 2017
We’re branching out from X 🔍 Find us on: 🌌 Bluesky: https://t.co/SROdTt4hm5 🔗 LinkedIn: https://t.co/3wM0fk1RPr 📸 Instagram: https://t.co/0ByavtnLmo 🌐 Website: https://t.co/CPPOMShCf4 📧 Newsletter: https://t.co/IZDAv3mgRp See you there for our usual #proteinscience updates!
0
0
0
Fill your (lab) stockings with IPI #antibodies! 🧪🧪 Our #glypican, #integrin & #epitopetag antibodies are now available. And by purchasing from IPI, a #nonprofit protein science lab, it’s really the gift that keeps on giving! https://t.co/r6yiCl5I4j
proteininnovation.org
0
2
8
@MitchellHo @theNCI We recently published an explainer to celebrate the release of our first #glypican antibodies. Take a look if you’re unfamiliar with the protein family!
proteininnovation.org
Hundreds of millions of years before humans evolved, a family of proteins came to be — first in worms, next in flies, then in mammals. The proteins,
0
0
0
New research from the @MitchellHo Lab (@theNCI) reveals 153 Glypican-3-associated proteins in liver cancer, including potential targets like AFP. Exciting steps for understanding #glypican biology & #cancer immunotherapy! https://t.co/gqlU8V5NZq
1
0
2
Check out this @SpecificaInc AI challenge (co-authored by André Teixeira, now at IPI) on #antibody affinity maturation, #affinity rank prediction for Ab discovery, and computational antibody design! @NatureBiotechl #proteinscience
nature.com
Nature Biotechnology - AIntibody: an experimentally validated in silico antibody discovery design challenge
0
1
0
Driving commercial development at a research institute requires the ability to fuse profit & nonprofit drivers. Mike Walden, IPI’s director of commercialization, sees a unique opportunity to build something extraordinary. Find out how in our profile! https://t.co/tM8mwADiwt
proteininnovation.org
Driving commercial development at a nonprofit institution is a challenge. The business models are complex and typically reliant on revenue streams outside
0
0
0
New #antibody release: our anti-#glypicans are now available! Order IPI’s unconjugated #recombinant GPC1, GPC3 & GPC4 antibodies through @Addgene today! https://t.co/l4j6jLM931
0
0
4
Throwback to our fall platform retreat in Essex Woods. We’re feeling especially grateful this week that we get to do science with such smart and hilarious colleagues!
0
0
0
The Baker Lab @UWProteinDesign recently hosted this powerful webinar on computational protein design. Take a journey through the history of this groundbreaking field, guided by some of the greats!
0
56
214
The brain is full of mysteries — like how glypican proteins act in axon guidance, synapse organization and neuron migration. “They regulate so many processes … we’ve only seen the tip of the iceberg,” says @D_dToro (@UBNeuroscience). Read more ➡️ https://t.co/KyUSICW4IK
0
1
3
This @Nature article did a great job capturing both the problems and potential solutions in finding and developing reliable, reproducible antibodies. We’re happy to be part of the piece. Read it here!
nature.com
Nature - Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
0
0
1
Antibody alert 📣📣 We’ve released new #recombinantantibodies targeting #glypican family members GPC1, GPC3 and GPC4! Browse our collection & order today! https://t.co/OYYPoNxb3a
1
0
3
Find out more about the glypican family on our blog!
proteininnovation.org
Hundreds of millions of years before humans evolved, a family of proteins came to be — first in worms, next in flies, then in mammals. The proteins,
0
0
0
Shout out to @SiddiquiLab, @dimatero, Luís Ribeiro @cnc_uc, Karl Murray @neuromab, @yiminzounew, Xin Yu @ucsdbiosciences, Rob Meijers & Mike Walden @ipiproteins!
0
0
1
Excited to host our first #antibody workshop on our #Neurexin/#Neuroligin panel today! It was great to see collaborator data on our rAbs & hear research updates related to #synapseformation, #axonguidance and more. Interested in joining? Email antibodies@proteininnovation.org!
1
0
2
Virtual seminar alert 📣📣 Tomorrow at 2 p.m. ET Sean Johnson (@NEBiolabs) joins us for an #IPISeminar on how to use #computationalmethods to explore the natural and non-natural #protein space. Find the link on our events calendar ➡️ https://t.co/6y1iTu2dsk
0
1
2
Deb Moshinsky’s no-stone-left-unturned approach to quality control is raising the bar for #antibody production at IPI, and in the wider the #antibodyreagent space. Find out more about her story and how she’s bettering IPI ➡️
proteininnovation.org
Deborah “Deb” Moshinsky is the type of process-motivated scientist that all labs require — but few are lucky to find. As the Director of Characterization
0
0
1
Take a look at this wonderfully comprehensive video from @QuantaMagazine — shows the significance of advances in #computationalproteindesign and #proteinstructureprediction, as recognized with the 2024 Nobel Prize in Chemistry! https://t.co/tx6wkNZ7ez
0
0
1
Antibody reliability is a huge issue, and recombinant antibodies can help. “They’re much more reproducible, you can standardize the process for them, and the user feedback is very positive,” says IPI’s Rob Meijers in a @Nature article published this week ➡️
Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this
0
0
2